A Comparative Analysis of the Effects of Cardioversion and Ablation on Anxiety, Sleep, and Quality of Life in Patients Diagnosed With Atrial Fibrillation

IF 2.8 3区医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS

Clinical Cardiology Pub Date : 2026-06-23 DOI:10.1002/clc.70388

Besey Oren, Busra Zehra Buyukkilic, Kubra Soydas, Ekin Oren

{"title":"A Comparative Analysis of the Effects of Cardioversion and Ablation on Anxiety, Sleep, and Quality of Life in Patients Diagnosed With Atrial Fibrillation","authors":"Besey Oren, Busra Zehra Buyukkilic, Kubra Soydas, Ekin Oren","doi":"10.1002/clc.70388","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background and Aims</h3>\n \n <p>This study aims to evaluate changes in quality of life, anxiety levels, and sleep quality before and after elective electrical cardioversion or ablation in patients diagnosed with chronic atrial fibrillation (AF).</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>This is a single-center, quasi-experimental study with a two-group, pretest−posttest design conducted between January and December 2024 in a training and research hospital in Istanbul. A total of 57 patients who underwent either cardioversion (<i>n</i> = 30) or ablation (<i>n</i> = 27) were included. Data were collected using the AFEQT Quality of Life Questionnaire, Beck Anxiety Inventory, and Pittsburgh Sleep Quality Index, and analyzed with R software. Statistical analyses included Student's <i>t</i>-test, Pearson's Chi-square, Fisher's exact test, paired two-sample <i>t</i>-test, and Welch's unequal variance <i>t</i>-test. A <i>p</i> value of < 0.05 was considered significant.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Post-treatment quality of life significantly improved in both groups (AFEQT: ablation +21, cardioversion +11 points). Anxiety levels decreased in the ablation group (–4.7 points), while sleep quality showed no significant change (<i>p</i> = 0.092). In the cardioversion group, significant improvements were observed in both anxiety and sleep quality (BAI –8.63; PSQI –1.10; <i>p</i> < 0.001). Regression analyses showed significant correlations between quality of life, anxiety, and sleep both before and after treatment.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>Improvements in quality of life were observed following both ablation and cardioversion procedures in patients with AF. Greater reductions in anxiety and sleep disturbance scores were observed in the cardioversion group compared with the ablation group.</p>\n </section>\n </div>","PeriodicalId":10201,"journal":{"name":"Clinical Cardiology","volume":"49 6","pages":""},"PeriodicalIF":2.8000,"publicationDate":"2026-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/clc.70388","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Cardiology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/clc.70388","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}

引用次数: 0

Abstract

Background and Aims

This study aims to evaluate changes in quality of life, anxiety levels, and sleep quality before and after elective electrical cardioversion or ablation in patients diagnosed with chronic atrial fibrillation (AF).

Methods

This is a single-center, quasi-experimental study with a two-group, pretest−posttest design conducted between January and December 2024 in a training and research hospital in Istanbul. A total of 57 patients who underwent either cardioversion (n = 30) or ablation (n = 27) were included. Data were collected using the AFEQT Quality of Life Questionnaire, Beck Anxiety Inventory, and Pittsburgh Sleep Quality Index, and analyzed with R software. Statistical analyses included Student's t-test, Pearson's Chi-square, Fisher's exact test, paired two-sample t-test, and Welch's unequal variance t-test. A p value of < 0.05 was considered significant.

Results

Post-treatment quality of life significantly improved in both groups (AFEQT: ablation +21, cardioversion +11 points). Anxiety levels decreased in the ablation group (–4.7 points), while sleep quality showed no significant change (p = 0.092). In the cardioversion group, significant improvements were observed in both anxiety and sleep quality (BAI –8.63; PSQI –1.10; p < 0.001). Regression analyses showed significant correlations between quality of life, anxiety, and sleep both before and after treatment.

Conclusion

Improvements in quality of life were observed following both ablation and cardioversion procedures in patients with AF. Greater reductions in anxiety and sleep disturbance scores were observed in the cardioversion group compared with the ablation group.

Abstract Image

查看原文本刊更多论文

心律转复和消融对房颤患者焦虑、睡眠和生活质量影响的比较分析

背景和目的：本研究旨在评估诊断为慢性心房颤动（AF）患者择期电复律或消融前后生活质量、焦虑水平和睡眠质量的变化。方法：这是一项单中心、准实验研究，采用两组、前测后测设计，于2024年1月至12月在伊斯坦布尔的一家培训和研究医院进行。共有57例患者接受了心脏复律（n = 30）或消融（n = 27）。采用AFEQT生活质量问卷、Beck焦虑量表和匹兹堡睡眠质量指数收集数据，并使用R软件进行分析。统计分析包括Student t检验、Pearson卡方检验、Fisher精确检验、配对双样本t检验和Welch不等方差t检验。结果：两组患者治疗后生活质量均有显著改善（AFEQT：消融+21分，复心+11分）。消融组焦虑水平下降（-4.7分），而睡眠质量无显著变化（p = 0.092）。在心律转复组中，观察到焦虑和睡眠质量的显著改善（BAI -8.63; PSQI -1.10; p）结论：AF患者在消融和心律转复后均观察到生活质量的改善。与消融组相比，在心律转复组中观察到焦虑和睡眠障碍评分的更大降低。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical Cardiology 医学-心血管系统

CiteScore

5.10

自引率

3.70%

发文量

189

审稿时长

4-8 weeks

期刊介绍： Clinical Cardiology provides a fully Gold Open Access forum for the publication of original clinical research, as well as brief reviews of diagnostic and therapeutic issues in cardiovascular medicine and cardiovascular surgery. The journal includes Clinical Investigations, Reviews, free standing editorials and commentaries, and bonus online-only content. The journal also publishes supplements, Expert Panel Discussions, sponsored clinical Reviews, Trial Designs, and Quality and Outcomes.